Close

Regulus Therapeutics (RGLS) Names Timothy Wright Chief Research and Development Officer

Go back to Regulus Therapeutics (RGLS) Names Timothy Wright Chief Research and Development Officer
REGULUS THERAP (NASDAQ: RGLS) Delayed: 2.20 --0 (-0%)
Previous Close $2.20    52 Week High $10.60 
Open $2.20    52 Week Low $2.13 
Day High $2.20    P/E 0.06 
Day Low $2.20    EPS $38.45 
Volume 1,700